BTG, a company based in London, UK, won European CE Mark clearance for its DC Bead LUMI radiopaque drug-eluting bead. This is the first such device available in Europe.
The beads can be loaded with either doxorubicin or irinotecan, commonly used chemo agents, and injected into tumors within the liver. Their radiopaque quality, thanks to a compound (Read more...)